Speaker Profile
Ph.D., Professor, Stanford U.
Biography
Stephen Quake is the Lee Otterson Professor of Bioengineering and Applied Physics at Stanford University. He has received numerous awards for his contributions to science and is one of only two dozen scientists elected to all three National Academies. Previously he was the Head of Science at Chan Zuckerberg Initiative (2022-2025), founding co-president of the Chan Zuckerberg Biohub (2016-2022), Investigator of the Howard Hughes Medical Institute (2006-2016), and Professor at the California Institute of Technology (1996-2005).
Talk
Beyond Genomics- Revealing Hidden Layers of Biology with AI
This talk describes a practical application of genomic knowledge. It describes how circulating cell-free nucleic acids, discovered in 1948, have been combined with high-throughput sequencing to develop non-invasive diagnostic tests that have replaced traditional biopsies for millions of patients in fields including pregnancy, transplant medicine, infectious disease, and cancer.n patterns.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures and Gad Getz, Broad Institute
PMWC Award Ceremony
• Steve Wozniak, Apple
• Greg Brockman, OpenAI
Fireside Chat
• Vinod Khosla, Khosla Ventures
• Greg Brockman, OpenAI
Target Discovery: Beyond Genomics – Revealing Hidden Layers of Biology with AI
• Keynote: Stephen Quake, CZ Biohub
• Chair: Cindy Lawley, Olink
• Aritro Nath, City of Hope
• Massa Shoura, Phinomics
• Omar Serang, DNAnexus
Accelerating Immunotherapy Discovery Through Multimodal AI
• Ron Alfa, Noetik
A Data-Integrated Approach to Target and Biomarker Discovery
• Liat Dassa, Cytoreason
Harmonizing Data to Accelerate Drug Discovery
• Vitalay Fomin, Numenos
Closing the Loop: Coupling AI with In Vivo Validation
• Gabriel Musso, Biosymetrics
Interpretable AI for Biomarker Discovery: Accelerating Drug Development
• Sanoj Punnen, University of Miami
• Shivanni Kummar, OHSU
• Mark Burkard, UI
Can AI Really Create the Next Blockbuster Drug?
• Chair: Amar Das, Guardant Health
• Ari Caroline, Weave Bio
• Dina Katabi, Emerald/MIT
• Andrei Georgescu, Vivodyne
• James Zou, Stanford
Gemini Digital Twins Accelerate Precision Medicine
• Collin Hill, Aitia
Scaling Rare Disease Discovery with AI
• Lisa Gurry, GeneDx
Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
• Andre Watson, Ligandal
Is AI the New Drug or the New Therapeutic Modality
• Chair: Alex Morgan, Khosla Ventures
• Michael J. Kahana, Nia Therapeutics
• Marc Tessier-Lavigne, Xaira
